Adjustment clinical trials

Explore recruiting adjustment clinical trials.

Recruiting adjustment studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adjustment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Using a fixed dosage of follitropin delta for ovarian stimulation for intrauterine insemination. Rekovelle for Intrauterine Successful Experience (RISE )

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR)

Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Assessing the Efficacy of a Single Measurement and Adjustment Strategy for DOACs in Frail Older Patients: Insights from the DOAC-FRAIL RCT. A step towards safe(r) DOAC utilization in the frail older population.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Optimization of the management of drepanocytosis patients treated with hydroxyurea: Interest of the pharmacological therapeutic follow-up

France

Therapeutic use (Phase IV) EU CTIS Study details

OPTI-TREX - Dose-adjustment of enoxaparin by a bayesian pharmacological approach in pediatric renal transplant recipients

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

SGM-LARRC: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carcino-embryonic antigen (CEA) monoclonal antibody, for locally advanced or recurrent rectal cancerpatients undergoing curative surgery.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjustment trials by city

Adjustment in Toronto Adjustment in Vancouver Adjustment in Montreal Adjustment in Calgary Adjustment in Edmonton Adjustment in Ottawa Adjustment in Winnipeg Adjustment in Quebec City Adjustment in Hamilton Adjustment in Kitchener Adjustment in London Adjustment in Halifax Adjustment in New York Adjustment in Los Angeles Adjustment in Chicago Adjustment in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease